Summary: A high performance liquid chromatography (HPLC) with isocratic ion-pair-re versed-phase separation and simultaneous UV-detection at 232 nm and 292 run is proposed as a method for the simultaneous determination of uric acid and cratinine in serum. The only sample preparation required is an appropriate dilution with the eluent and membrane filtration on non-adsorbent 0.2 μτη membrane-filtration-devices.
photometric methods do not yield plausible results or when creatinine monitoring is critical -for example in transplantation surgery -the use of a HPLC method is justified instead of photometric methods (i.z.Jaffe's method) after adsorption to Fuller's earth or the determination of a sample blank after enzymatic creatinine-degradation are performed (5) . In order to test inaccuracy, NIST-SRM-909 human serum control material was used, additionally method comparisons were performed with n = 5 pooled serum specimens and n = 50 individual serums specimens. As a comparison method for creatinine a reference method, an isotope dilution-gas chromatography-mass spectrometry (ID-GC-MS) with [ 13 C, 15 N 2 ]creatinine as internal standard was used, for uric acid a candidate reference HPLC method (1) was choosen.
Materials and Methods

Chemicals
The uric acid (purity 99.7% ± 0.1%) and creatinine (purity 99.8% ± 0.1%) used for preparation of the standard solutions were Standard Reference Materials (SRM913 resp. SRM914a) from the National Institute of Standards and Technology, Washington D. C. 20234, U. S.), [ I3 C,
I5
C 2 ]creatinine used as internal standard in ID-GC-MS-measurements was a generous gift of Dr. Kobold, Boehringer Mannheim GmbH, Werk Tutzing, N-Methyl-N-trimethylsilyltrifluoroacetamide as well as pyridine (Silylation Grade Solvent) was supplied by Macherey & Nagel (D ren, Germany), creatinine-imidohydrolase and uricase were from Boehringer Mannheim (Mannheim, Germany), all other chemicals were of analytical grade and purchased from Merck (Darmstadt, Germany), SIGMA (Munich, Germany) and from Baker (Gro -Gerau, Germany). Bakerbond SPE-solid phase extraction cartridges were from Baker (Gro -Gerau, Germany). Deionized water was prepared with a Milli-Q apparatus (Millipore GmbH, Eschborn, Germany).
Samples
The control material used for checking inaccuracy of the methods was Human Serum SRM 909 from the National Institute of Standards and Technology, Washington D. C. 20234, U. S.). The other control materials were Precinorm U (Chargen-Nr. 16915101) and Precipath U (Chargen-Nr. 16913801) from Boehringer Mannheim GmbH (Mannheim, Germany).
For the recovery experiments 5 pools were prepared from patient sera. For the method comparisons 50 patient samples, 20 in the normal range and 30 in the pathological range, were used. All specimens were collected in Sarstedt-Monovettes with separation-gel. After centrifugation serum was obtained.
Instruments and settings
New combined high performance liquid chromatography
The HPLC was performed on a Bruker LC-21 Chromatographie system with a LC-51 autoinjector and a tuneable Gynkotec 4-wavelength detector Model tuned at 232 nm for the detection of creatinine and 292 nm for the detection of uric acid. System controlling data acquisition, integration and calibration was performed with Bruker Chromstar V3.20, the absorbance data at 232 nm and 292 nm were acquired simultaneously.
For the candidate HPLC-method for uric acid the Chromatographie conditions were as described in I.e. (1), for the new combined HPLC-method presented here, the simultaneous determination of uric acid and creatinine, a μBondapak CIS (10 μηι particle-size), 300 mm X 3.9 mm analytical column (Waters Chromatographie, Eschborn, Germany) with μBondapak CIS precolumn insert was used. The eluent buffer A consisted of 27. f 5 mmol/1 sodium dihydrogenphosphate, 2.5 mmol/1 octanesulptionic acid, pH 4.2, acetonitrile, volume fraction 0.1, column purging was performed with eluent buffer B consisting of 2.5 mmol/1 sodium dihydrogenphosphate, 2.5 mmol/1 octanesulphonic acid, acetonitrile, volume fractions 0.60. The pH of buffer B was set to 4.2 by adding concentrated NaOH. The flow-rate was 1 ml/min. The injection volume was 50 μΐ for all samples. The duration of one chromatography was 8 min. Every 15 chromatographies the column was purged with Buffer B for 5 min and the column was then equilibrated with Buffer A for 35 min.
Candidate reference high performance liquid chromatography for uric acid
The candidate reference HPLC was performed identically as described before (1).
Isotope dilution-gas chromatography-mass spectrometry of creatinine
The instrument used was a Finnigan 1020 combined gas-chromatograph quadrupole-mass-spectrometer with Perkin-Elmer Sigma 3 gas-chromatograph, equipped with a Permabond FS-SE-52, 0.2*5 μπα, 25 m X 0.32 mm ID capillary column (Macherey & Nagel, D ren, Germany).
GD-conditions: The carrier gas was helium at 70 kPa inlet pressure, the split^exit was set at 30 ml/min, the injector temperature was 190 °C, the oven temperature was isothermal 170 °C, the transfer line has heated to 190°C. The retention-time of the creatininederivative was 3.5 min. 
MS-conditions
Procedures and measurements
Weighing procedures
Uric acid (SRM 913), creatinine (SRM 914) and the isotopicaliy labelled creatinine were weighed on a micro balance (Mikrowaage 708501, Fa. Sartorius, G ttingen, Germany). All other weighing procedures, including all required calibrations of volumetric devices, were done on a semimicro balance (Halbmikrowaage 2004 MP, Fa. Sartorius, G ttingen, Germany).
Preparation of stock standards and reconstitution of control sera
The reconstitution of lyophilized control sera as well as the preparation of the uric acid standards was performed as previously described (1), giving a stock standard concentration for uric acid of 357 μηιοΐ/ΐ. The uric acid stock standard was freshly prepared every day. Creatinine stock-standards were prepared by dissolving the weighed SRM 914 -2.3 mg for HPLC, 1.5 mg for ID-GC-MS -in 100 ml, giving a stock standard concentration for creatinine of 203 μηιοΐ/ΐ for HPLC-measurenients and a stock standard concentration for creatinine of 133 μηιοΐ/ΐ for ID-GC-MS-measurements. The creatinine stock standard was stable for at least one week at 4 °C. As internal standard for the ID-GC-MS 3 mg of the isotopicaliy labelled creatinine were dissolved in 25 ml HPLC-water, giving a stock standard concentration for the internal standard of 1061 μηιοΐ/ΐ. This internal standard was prepared once, and aliquots of 1 ml were freezed at -70 °C.
· *
Serum dilutions
All sera, control sera, patient sera and serum pools were diluted with a gravimetrically calibrated Microlab 1000 (Fa. Hamilton, Darmstadt, Germany). The diluted serum samples were filtered through membrane filtration devices with a pore diameter of 0.2 μπι (Sartorius GmbH, G ttingen, Germany).
Measurements with the new combined HPLC
For the new combined HPLC-method presented here, the standards used for calibration contained both analytes. The calibration standards were prepared freshly every day with the Microlab 1000 system. Equal amounts of the stock standard solutions of creatinine and uric acid were mixed and diluted with elution buffer A to give standards with 0.05c slock , 0.1 c^o«*, and 0. Measurements with an area response out of the calibrated concentration-range were rechromatographed in an appropriate second dilution which in our study for the most cases was a dilution of 1 : 20. Only 7 sera with creatinine concentration above 600 μπιοΐ/ΐ required a 1 : 30 dilution for the determination of creatinine, in the case of serum concentrations below 50 μιηοΐ/ΐ and/or uric acid serum concentrations below 178 μπιοΐ/ΐ the serum dilution 1 : 5 was chromatographed. All serum, SRM 909 and standard samples were prepared twice. The measuring sequence in this study was as follows: low standard in triplicate, medium standard in triplicate, high standard in triplicate, SRM 909 in triplicate, 5 serum samples in triplicate, SRM 909 in triplicate, 5 serum samples in triplicate. Then in the second run the procedure was repeated with the second dilution of all standards, the SRM 909 and the 10 sera.
Calibration and calculation for the new combined HPLC
For the new method, the calibrations for creatinine as well as uric acid were based on peak areas; linear concentration peak-area-relationships were used for both analytes, whereby the calibration curves showed neither an intercept significantly deviating from the origin nor a significant non-linearity.
Measurements with the candidate reference HPLC for uric acid
All serum samples were treated in this case like the reconstituted control sera in that study (1) .
/fror the first pipetting step, it is necessary to fit individually the aliquot of each serum sample to a constant amount of internal standard to give an isotope ratio (unlabelled/labelled) in the final ID-GC-MS measurement between 0.9 and 1.1. Therefore 50 μΐ of the internal standard were added to an anliquot of serum (typically between 100-600 μΐ), which contained about 6 μg creatinine. This is the most critical volumetry in the ID-GC-MS procedure and has to be performed very exactly. Then 0.1 mol/1 HC1 with an amount of half of the volume of the serum aliquot was added and finally HPLC-water was added to give a final volume of 1 ml. This sample was mixed and equilibrated for 2 h. Next a solid-phase extraction of the sample was performed on Bakerbond SPE-columns, which were previously conditioned with 3 ml methanol and 3 ml HPLCwater. After washing the column with 3 ml water, the creatinine was extracted from the columns with 4 ml eluent-buffer (6.5 mmol/ 1 Na 2 HPO 4 , 2.5 mmol/1 NaH 2 PO 4 , 150 mmol/1 NH 4 CO 3 , pH 8.0), the first 2 ml of the column-eluate was discarded. The 2 ml eluate was evaporated under a nitrogen-stream at 60 °C to dryness, the residue was further processed as described for the evaporated standard samples. From each standard, control serum and patient serum, two samples were prepared for ID-GC-MS and each sample was chromatographed in triplicate.
Calibration and calculation for the candidate reference HPLC for uric acid
For the GC-MS measurements 1.5 μΐ were injected, and peak-integration was performed with the Finnigan-1020 Software. Subsequent calculations were performed using the procedure described by Siekmann (6) .
Results
Specificity
The chromatogram of a uric acid/creatinine-standard is shown in figure la, the chromatogram of a control serum is shown in figure Ib and that of a patient serum sample in figure Ic. For the patient serum a much more complicated matrix compared to the control material is evident in the chromatogram at 232 nm. After enzymatic treatment with creatinine-imidohydrolase and uricase interfering substances underlying the peaks of the analytes could not be detected in the samples used in this study.
Calibration and calculation for the candidate reference HPLC for uric acid
For the candidate reference HPLC for uric acid, a calibration method previously published (1) was used.
Measurements with the ID-GC-MS for creatinine
Internal standard (50 μΐ) were added to 300 μΐ (Standard A), 400 μΐ (Standard B), 500 μΐ (Standard C) creatinine-stock-standard with a Microlab 1000 (Hamilton, Darmstadt, Germany), HPLC-water was added to give a final volume of 1 ml, then the standards were evaporated at 60 °C under a stream of nitrogen to dryness. For the determination of the isotope-ratio of the unlabelied standard and the labelled internal standard, 400 μΐ of the stock standard or 50 μΐ of the internal standard (both containing about 6 μg creatinine) were were evaporated directly. Fifty μΐ of 1 : 1 (v : v) mixture of Nmethyl-N-trimethylsilyltrifluoracetamide and pyridine (dried over molecular sieve) was added to the dried residue and the derivatisation was performed for 40 min at 60 °C.
Imprecision
The imprecision of the Chromatographie method and the applied peak integration procedure was determined from the areas obtained for the triplicate measurements of the samples. This imprecision was less than 0.2% for the standards, less than 0.3% for SRM 909 and less than 0.6% for the serum samples. The deviations between two different dilutions never exceeded 0.4% for all samples measured in this study.
The within-run imprecision has been calculated for the means of the triplicates of three standard samples and five serum-pools from n = 10 runs and was for both analytes less or equal than 0.5% (CV) in the case of standards and less or equal than 0.8% (CV) in the case of pool sera (tab. la). The day-to-day imprecision has been calculated for aliquots of the five serum-pools at η = 10 different days; the aliquots of the pools have been stored at -70 °C and were equilibrated at room temperature before processing after thawing. Only the pool-sera in the normal-range (Pool 1 and 2) show a CV of 1.1% in the case of creatinine, all other imprecisions determined for both analytes were less or equal than 1.0% (tab. Ib). Table 2 shows the imprecisions for the same serum pools obtained for creatinine by ID-GC-MS.
Inaccuracy Table 3 shows the recoveries, of added uric acid and creatinine standards to a pool serum. Only in one case for the creatinine determination was the deviation -0.7% with an CV of 0.5%, for all other recoveries the deviations from 100% were less than the CV for both analytes. For the determination of creatinine by ID-GC-MS all recoveries determined had a deviation from 100% less than the CV.
The inacpuracy of the HPLC-method for the simultaneous determination of uric acid and creatinine was checked with the control material.SRM-909. The coefficient of variation for this control material, obtained from Tab. Ib Day to day imprecision for the method for the simultaneous determination of uric acid and creatinine, calculated for five human pool sera from η = 10 runs. Tab. 4 Summary of the data for the calculated deviations between the presented combined method for the simultanous determination of creatinine and uric acid and the chosen reference methods The statistics for the deviations between the results obtained with the combined method and the reference methods are summarized in table 4 .
Conclusions
The aim of this study was the evaluation of a high-performance liquid chromatography for the simultaneous determination of creatinine and uric acid in serum. The imprecision was less or equal than 1.1% for both analytes, and it was below 1% for control material; the ina&· curacy in the standard recovery experiments was even lower. The imprecision data from the triplicate chromatographies of the samples suggest that only one measurement of each serum dilution for all samples is required. The method was tested against a reference method for the determination of creatinine (7) and a candidate reference method for the determination of uric acid (1). For η = 55 human serum samples we found very good correlations between the results for both analytes obtained with the combined method and the methods choosen as reference. Ninety-six percent of the samples had a difference of the analytical results for creatinine between the method presented and the ID-GC-MSmethod less than or equal to 3.6%. In the case of uric acid, 98% of the samples showed a difference less than or equal to 2.5%. For uric acid the results are comparable to those for control materials and in the case of creatinine it is expected that due to the simpler matrix of those control materials the observable deviations should be even less than those found for patient samples.
Recently, several methods for the determinations of creatinine have been published, mostly based on cationexchange-HPLC (8-11). Rosano et al. proposed a method based on this principle as a reference method (12) and Linnet et al. proposed a candidate reference method where a sample preparation procedure with cation-exchange chromatography is followed by reversedphase-HPLC and enzymatical quantification (13) . The principle of ion-pair-gradient HPLC of serum-ultrafiltrates has also been utilized for the development of candidate reference methods (14) . » For the separation of uric acid and creatinine, the most suited separation system was the ion-pair reversed-phase chromatography, where an added ionic modifier, in this method octanesulphonic acid, will react under certain conditions with cationic serum components to yield ionpairs, which will retard the elution by a reversed-phase stationary phase. This principle has been previously used for the HPLC of creatinine, but all methods described may introduce additional sources of imprecision and inaccuracy due to their complex sample preparation; a direct injection of a diluted and filtered serum or control material can minimize these analytical problems.
The data obtained for day-to-day imprecisions as well as those for the recoveries show the advantage of the method presented here. Moreover the method evaluated in this study does not require a pump with gradient capabilities, the system only needs to be equipped with an eluent switching device, and further only a one-wavelength-tuneable UV-detector with wavelength switching is needed as the simultaneous acquisition at 232 nm and 292 nm is not absolutely required.
The method was primarily developed for clinical purposes. Here the determination of creatinine is a crucial element of patient surveillance, for example following transplantation surgery, where the drug-treatjhent of the transplanted patients is most complex and metabolism and pharmacokinetics are often in disorder. In those cases the spectrophotometrical determination of creatinine, fully enzymatic or special modifications of the Jqffe-method do not fit the requirements due to the often overly complex interferences occuring in the samples of these patients. The HPLC-method presented will therefore be of value as an "in lab reference" for the precise monitoring of the serum-concentration of creatinine and uric acid in those cases where the classical methods are suspected of giving erroneous results and the determination of these analytes is critical for the treatment of the patient.
The method presented here is the first high-performance-liquid-chromatography for the simultaneous determination of creatinine and uric acid, where a full method evaluation including a method comparison against established candidate reference method was performed. The method can be applied in clinical cases where spectrophotometric methods, which are more unspecific and more susceptible to interferences, have to be replaced. Clinical investigations concerned with this field are in progress and the applicability of the method for urine is under study.
